Dry Needling & Trigger Point Compression Release in Neck Pain

Health Education Research Foundation (HERF)

Status: Completed

Conditions: Neckache; Neck Muscle Issue; Trigger Point Pain, Myofascial; Muscle Tightness; Neck Pain

Treatments: Other: Dry Needling

Study type: Interventional

Funder types: Other

Identifiers

NCT05870904

070/BPMI/ Saad Tariq DPT

Details and patient eligibility

About

This randomized control trial was conducted to investigate the efficacy of trigger point dry needling which is a modern treatment intervention compared with ischemic compression release in the patients having neck pain due to myofascial trigger points.

Full description

Many treatment protocols have been used in the clinical arena for the improvement of neck pain but un-availability of follow-up studies and lack of evidence of modern treatment interventions are few shortcomings a researcher faces. Thus, a need stands up to address these perspectives for newer treatment strategies. This randomized control trial is conducted to investigate the efficacy of trigger point dry needling which is a modern treatment intervention compared with ischemic compression release in the patients having neck pain due to myofascial trigger points. Findings of this research will assist in creating awareness about better treatment intervention for trigger point release among medical community.

Enrollment: 30 patients

Sex: All

Ages: 20 to 40 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients between the age group of 20 to 40 years.
• Both Male and female patients.
• Patients presenting with neck pain due to MTrP's.
• The presence of a palpable taut band in the neck region.
• Patients reporting typically referred pain pattern of the MTrP in response to compression.

Exclusion criteria

• Patients with any associated comorbidities such as hypertension and diabetes.
• Patients with known history of fibromyalgia syndrome, whiplash injury, cervical spine surgery fracture and cervical radiculopathy.
• Patients with any systemic disease such as rheumatism and tuberculosis or cervical myelopathy and multiple sclerosis.
• Patients with history of myofascial trigger point therapy one month prior to enrollment.
• Patients with non-cooperative attitude, fear or any contraindications to needling.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

30 participants in 2 patient groups

Dry Needling Group

Experimental group

Description:

Received dry needling through the insertion of fusiform needle for the trigger point release on 3 days a week aimed at pain relief.

Treatment:

Other: Dry Needling

Ischemic Compression Group

Active Comparator group

Description:

Received ischemic compression release through thumb pressure for trigger points on 3 days a week.

Treatment:

Other: Dry Needling